XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A  preferred stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2022   10,000 116,482,899      
Beginning balance at Mar. 31, 2022 $ 469,825 $ 0 $ 12 $ 824,796 $ 404 $ (355,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     41,259      
Stock options exercised and restricted stock units vested and settled 21     21    
Capital contribution – stock-based compensation 132     132    
Stock-based compensation 7,555     7,555    
Foreign currency translation adjustments (667)       (667)  
Net loss (40,373)         (40,373)
Ending balance (in shares) at Jun. 30, 2022   10,000 116,524,158      
Ending balance at Jun. 30, 2022 436,493 $ 0 $ 12 832,504 (263) (395,760)
Beginning balance (in shares) at Mar. 31, 2022   10,000 116,482,899      
Beginning balance at Mar. 31, 2022 469,825 $ 0 $ 12 824,796 404 (355,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (88,301)          
Ending balance (in shares) at Sep. 30, 2022   10,000 116,614,088      
Ending balance at Sep. 30, 2022 395,748 $ 0 $ 12 840,661 (1,237) (443,688)
Beginning balance (in shares) at Jun. 30, 2022   10,000 116,524,158      
Beginning balance at Jun. 30, 2022 436,493 $ 0 $ 12 832,504 (263) (395,760)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital contribution – stock-based compensation 106     106    
Stock-based compensation 8,051     8,051    
Foreign currency translation adjustments (974)       (974)  
Restricted stock units vested and settled (in shares)     89,930      
Net loss (47,928)         (47,928)
Ending balance (in shares) at Sep. 30, 2022   10,000 116,614,088      
Ending balance at Sep. 30, 2022 395,748 $ 0 $ 12 840,661 (1,237) (443,688)
Beginning balance (in shares) at Mar. 31, 2023   10,000 130,329,863      
Beginning balance at Mar. 31, 2023 362,494 $ 0 $ 13 927,976 852 (566,347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     235,566      
Stock options exercised and restricted stock units vested and settled 890     890    
Capital contribution – stock-based compensation 35     35    
Stock-based compensation 10,653     10,653    
Foreign currency translation adjustments (270)       (270)  
Net loss (73,937)         (73,937)
Ending balance (in shares) at Jun. 30, 2023   10,000 130,565,429      
Ending balance at Jun. 30, 2023 299,865 $ 0 $ 13 939,554 582 (640,284)
Beginning balance (in shares) at Mar. 31, 2023   10,000 130,329,863      
Beginning balance at Mar. 31, 2023 362,494 $ 0 $ 13 927,976 852 (566,347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (132,599)          
Ending balance (in shares) at Sep. 30, 2023   10,000 131,442,024      
Ending balance at Sep. 30, 2023 251,811 $ 0 $ 13 950,231 513 (698,946)
Beginning balance (in shares) at Jun. 30, 2023   10,000 130,565,429      
Beginning balance at Jun. 30, 2023 299,865 $ 0 $ 13 939,554 582 (640,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     876,595      
Stock options exercised and restricted stock units vested and settled 148     148    
Capital contribution – stock-based compensation 28     28    
Stock-based compensation 10,501     10,501    
Foreign currency translation adjustments (69)       (69)  
Net loss (58,662)         (58,662)
Ending balance (in shares) at Sep. 30, 2023   10,000 131,442,024      
Ending balance at Sep. 30, 2023 $ 251,811 $ 0 $ 13 $ 950,231 $ 513 $ (698,946)